Research programme: o-glycan targeted therapeutics - Leiden University Medical Center/Tacalyx
Latest Information Update: 24 Aug 2023
At a glance
- Originator Tacalyx
- Class Antibodies; Antineoplastics; Diagnostic agents
- Mechanism of Action Tumour associated carbohydrate antigen inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Colorectal cancer